FDA Inspection 1134103 — Cambridge Isotope Laboratories, Inc.

Cambridge Isotope Laboratories, Inc. — FEI 3010827078

The FDA completed an inspection of Cambridge Isotope Laboratories, Inc. on Dec 9, 2020 in Tewksbury, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 9, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tewksbury, MA (United States)

Citations

IDCFRDescription
1776321 CFR 212.20(d)Determination need for investigation
1777021 CFR 212.40(a)Suitable for intended use
1777321 CFR 212.40(b)Written specifications - containers and closures
1781221 CFR 212.50Adequate controls (general)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.